2014 “Towards an HIV Cure” symposium Melbourne Following in vitro culture with myeloid dendritic cells, negative regulators of T cell activation are expressed.

Slides:



Advertisements
Similar presentations
New concepts in HIV: HIV immunopathogenesis, treatment and vaccine strategies - report back from pre-conference Nicolas Chomont VGTI-Florida.
Advertisements

Purging the HIV-1 Reservoir Through the Disruption of the PD-1 Pathway
The Journal of Immunology, 2013 March 27; 190: , IF=5.52
Unique integration patterns in an in vitro model of HIV-1 latency. Suha M. Saleh, Dimitrios Vatakis, Andrew Harman, Anthony Cunningham, Paul U. Cameron,
Contribution of the immune system to HIV persistence Sharon R Lewin Director, Infectious Disease Unit, Alfred Hospital Professor, Department of Medicine,
Gag-positive reservoir cells can be identified by a new technique and can be cleared by CTL ? Una O’Doherty June 29, 2013.
Controversies in HIV Cure Research Debate 1. Is there ongoing replication under HAART? Mario Stevenson and Frank Maldarelli Moderator: Steve Deeks.
1 HIV Curative Strategies: Key Research Priorities Deeks S, et al., (2013) Nat Rev Immunol. 12(8):
Memory CCR6+CD4+ T-Cells are Selectively Imprinted with a Transcriptional Program Favorable to Productive HIV-1 Infection Patricia Monteiro, Jean-Philippe.
Myeloid dendritic cells and HIV latency in resting T-cells Nitasha A Kumar, Vanessa A Evans, Suha Saleh, Candida de Fonseca Pereira, Paula Ellenberg, Paul.
Lecture outline Signals for T cell activation
Alternative RNA splicing in latently infected T cells generates chimeric cellular:HIV mRNAs with the potential to generate Tat and reactivate infection.
2014 “Towards an HIV Cure” symposium Melbourne A novel assay that precisely measures the size of the latent HIV reservoir reveals that ART-nai ̈ ve individuals.
2014 “Towards an HIV Cure” symposium Melbourne The Immune Checkpoints PD-1, LAG-3 and TIGIT are Biomarkers of HIV Infected Cells During ART and Identify.
Signals for T cell activation Costimulation and the B7:CD28 family
Cell- and Tissue-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1-Expressing CD4+ T cells H Hatano 1, V Jain 1, PW Hunt.
Enhancement Of T-Cell Immunity To Osteosarcoma By Modulation Of Programmed Death Receptor Pathway Pooja Hingorani, Danielle Lussier, Joseph Blattman.
The role of PI3K signaling pathways in HIV-1 infection of resting CD4+T-cells Suha Saleh, Paul Cameron, Georgina Sallmann, Anthony Jaworowski, and Sharon.
Concepts in Basic Science and Translational Research
2014 “Towards an HIV Cure” symposium Melbourne
Novel Approaches: Treatment and HIV Pathogenesis L. Trautmann, Ph.D. VGTI Florida.
Anti-HIV Antibody Responses Reflect the Quantifiable HIV Reservoir Size Sulggi Lee, M.D., Ph.D. Assistant Professor of Medicine University of California,
Non-Infectious Papilloma virus–like Particles (VLPs) inhibit HIV-1 replication: Implications for immune control of HIV-1 replication by IL-27. Laboratory.
A new molecular mechanism for HIV-1 latency HIV latency in primary T cells: natural activation/purging by DCs Ben Berkhout Academic Medical Center University.
AB CD T-cell Phenotypic Profile in Pregnancy: Link Between Immune Activation and Exhaustion N Shah 1, N Imami 1, M Johnson 1. 1 Imperial College London,
Learning About an HIV Cure by Doing Studies in HIV+ Subjects Alan Landay, PhD Professor and Chairman Department of Immunology/Microbiology Rush University.
Myeloid dendritic cells induce HIV-1 latency in non- proliferating CD4 + T cells IAS WORKSHOP, 16 & 17 JULY 2010.
1 Molecular Mechanisms for gp160-Enhanced Apoptosis Keith J. Micoli, Olga A. Mamaeva, George Pan, Eric Hunter and Jay M. McDonald University of Alabama.
Peripheral T follicular Helper Cells (pTfh)
Immune Tolerance Kyeong Cheon Jung Department of Pathology Seoul National University College of Medicine.
Title Box. “Towards an HIV Cure”: Presentation Outline -Why do we need a cure? -Is a cure feasible and what type of cure can we reach? -Why does HAART.
IAS Members Meeting July 19th 2011 Achievements and learning over the past 30 years: what do we need next? Françoise BARRÉ-SINOUSSI Regulation of Retroviral.
HIV: Science, Sex and Society. Lecture 1. Mechanisms of viral persistence in the face of antiviral therapy. Mario Stevenson, Ph.D Department of Medicine.
The Future of HIV/AIDS: The Road to a Cure. How HIV persists during therapy?  Ongoing viral replication occurs in subjects on suppressive HAART (TW Chun,
Dendritic Cell Subsets June 3, 2005 MIMG 261 Stephan Krutzik, Ph.D.
Cancer immunotherapy: an update
Immunological tolerance and immune regulation -- 1
Background  HIV-1 infection persists in reservoirs and leads to progressive depletion of CD4+ T-cells even in subjects with slow disease progression 
Davey Smith, MD Professor of Medicine University of California San Diego La Jolla, California When Will It All Be Over? HIV Cure Efforts Los Angeles, California:
#AIDS2016 HIV Persists in Colon and Blood CCR6+ T-Cells During Viral Suppressive ART Jean-Pierre Routy on behalf of : A. Gosselin, T.
Summary and Conclusion Hypothesis and Rationale
Immunological tolerance and immune regulation -- 1
Side Scatter Forward Scatter Lineage CD1c CD141 CD303 lineage negative
CX 3 CR1 + CD115 + CD135 + common macrophage/DC precursors and the role of CX 3 CR1 in their response to infl ammation Cedric Auff ray , Darin K.
Immune Tolerance Kyeong Cheon Jung Department of Pathology
Figure 1 CTLA-4 and PD-1–PD-L1 immune checkpoints
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 1 Postulated mechanisms of action of PD‑1, PD‑L1 and PD‑L2
The block-and-lock approach
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Why we should ‘shock and kill’
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
Ana C. Anderson, Nicole Joller, Vijay K. Kuchroo  Immunity 
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 The role of CTLA4 and PD1 in T cell activation
Volume 53, Issue 4, Pages (October 2010)
Mechanisms of immune escape in the tumor microenvironment.
Volume 18, Issue 5, Pages (January 2017)
Nat. Rev. Endocrinol. doi: /nrendo
Immune Tolerance Kyeong Cheon Jung Department of Pathology
Nat. Rev. Rheumatol. doi: /nrrheum
In Vivo Role of pDCs in Regulating Adaptive Immunity
Volume 38, Issue 2, Pages (February 2013)
The role of IFN in viral infection over time
Fig. 3 BMS blocks functional responses in primary immune cells driven by IL-23 and IL-12. BMS blocks functional responses in primary immune.
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Plasmacytoid Dendritic Cells in Melanoma: Can We Revert Bad into Good?
The role of IFN in viral infection over time
Volume 18, Issue 5, Pages (January 2017)
RIL21 and checkpoint blockade restore IFNγ production in Tim-3+PD-1+ intratumoral NK cells from cancer patients. rIL21 and checkpoint blockade restore.
Presentation transcript:

2014 “Towards an HIV Cure” symposium Melbourne Following in vitro culture with myeloid dendritic cells, negative regulators of T cell activation are expressed preferentially on latently infected CD4 + T cells Vanessa A. Evans, Renée M. van der Sluis, Nitasha A. Kumar, Rafick-Pierre Sekaly, Remi Fromentin, Nicolas Chomont, Paul U. Cameron, Sharon R. Lewin

Infection of resting CD4 + T cells: a role for cell-cell interactions Unactivated resting cells Resting CD4 + T cell Dendritic Cells Evans et al. PLoS Pathogens 2013 Endothelial Cells Shen et al. J Virology 2013 Ex vivo tissue blocks Eckstein et al. J Virology 2001

Myeloid DC induce latency in resting memory CD4 + T cells  Not mediated by soluble factors: CCL19, CCL21, CXCL10, IL-10, IL-6  Close DC-T cell proximity required for induction of latency Non-proliferating CD4 + T cells Evans et al. PLoS Pathogens 2013

Negative regulators and latency  Negative regulators dampen the immune response and can be found on exhausted T cells Ahmed et al. J Immunol 2010; Day et al. Nature 2006  Latently infected T cells express negative regulators of T cell activation eg. PD-1, Tim-3 and TIGIT Chomont et al. Nat Med 2010; Fromentin et al. CROI 2014  Blocking PD-L1/PD-1 in vivo restores the SIV- specific cellular and humoral immune responses, improves viral control and reduces immune activation Velu et al. Nature 2009; Dyavar Shetty et al. J Clin Invest 2012; Finnefrock et al. J Immunol 2009

Hypothesis Expression of negative regulators during DC-T cell interactions may actively suppress viral replication and maintain latency

CD11c CD123 Plasmacytoid DC Myeloid DC PBMC Resting CD4 + T cells CD69CD25HLA-DR + mouse anti-human CD8, CD11b, CD14, CD16, CD19, CD69, HLA-DR Magnetic Bead Depletion CD4 CD3 >98% Resting CD4 + T cells Bulk DC PBMC + mouse anti-human CD3, CD11b, CD19 Magnetic Bead Depletion Lineage Cocktail HLA-DR Dendritic Cells

Resting CD4 + T cells eFluor 670 DC added 1:10 AND R5-EGFP-HIV-1 (2h pulse) 1 day Productive infection Latent infection >99% aCD3/aCD28 3 Days Activation + integrase inhibitor L8 Non-proliferating eFluor670 hi Not productively infected EGFP - EGFP eFluor670 eFluor670 hi EGFP - CD4 + T cells Day 5 p.i.

Expression of negative regulators following DC-T cell co-culture eFluor-resting CD4 + T cells + mDC OR R5-EGFP-HIV-1 (2h pulse) 1 day Baseline PD-1/Tim-3/CTLA-4 Phenotyping on days 1, 2, 3, 4, 5 post-infection ViableSingle cellsT cells eFluor hi EGFP - PD-1, Tim-3 and CTLA-4 EGFP eFluor HLA-DR CD3 SSC-H SSC-W FSC-A SSC-A

Days post-infection % Positive cells Expression of negative regulators following DC-T cell co-culture PD-1Tim-3 CTLA-4 % Positive cells Days post infection Mean fold change 24 No change n=3 Days post-infection Mean fold change 32 ()

Differential expression of negative regulator ligands on mDC and pDC Leitner PLoS Pathog 2013

Are PD-1 hi cells enriched for latency? eFluor hi EGFP - CD4 + T cells Anti-PD-1 Latent infection PD-1 lo/- cells PD-1 hi cells EGFP eFluor670 aCD3/28 +L8

HIV latency is enriched in PD-1 hi cells

HIV latency is enriched in Tim3 hi cells eFluor hi EGFP - CD4 + T cells Anti-Tim-3 Tim-3 lo/- cells Tim-3 hi cells

Summary  Myeloid DC facilitate establishment of HIV latency in resting memory CD4 + T cells via direct infection  Negative regulators PD-1 and Tim-3 but not CTLA-4 are up- regulated on resting CD4 + T cells upon co-culture with mDC  Negative regulator ligands are differentially expressed by mDC and pDC  mDC-induced HIV latency is enriched in PD-1 hi and Tim-3 hi cells

PD-L1 PD-1 PD-1/-L1 blockade Cell death  virus production  immune clearance Blocking interactions between negative regulators and their ligands EGFP + productively infected CD4 + T cells Latent Infection in sorted eFluor hi EGFP - CD4 + T cells

Implications  mDC may facilitate ongoing latent infection of resting CD4 + T cells leading to replenishment of the reservoir  Disrupting the function of PD-1 and/or Tim-3 could potentially be exploited to inhibit replenishment of the reservoir and/or reverse latency

Acknowledgements Monash University –Sharon Lewin –Paul Cameron –Renée van der Sluis –Nitasha Kumar –Suha Saleh –Candida da Fonseca AMREP Flow Cytometry –Geza Paukovicks –Michael Thompson –Jeanne Le Masurier –Phil Donaldson VGTI Florida –Rafick Sekaly –Nicolas Chomont –Remi Fromentin University of Melbourne –Damian Purcell